Liste d'obligations internationales ( Toutes )
| Société émettrice | Code ISIN | Devise | Coupon | Montant minimal | Maturité | Prix sur le marché | |
| Gilead Medica | US375558BY84 | USD | 1.65% | 1 000 USD | 30/09/2030 | 89.3906 | |
| Gilead Medica | US375558AU71 | USD | 4.4% | 2 000 USD | 30/11/2021 | Echue | |
| Gilead Medica | US375558BH51 | USD | 1.95% | 2 000 USD | 01/03/2022 | Echue | |
| Gilead Medica | US375558AR43 | USD | 2.4% | 2 000 USD | 01/12/2014 | Echue | |
| Gilead Medica | US375558AQ69 | USD | 4.5% | 1 000 USD | 01/04/2021 | Echue | |
| Gilead Medica | US375558AY93 | USD | 2.35% | 2 000 USD | 01/02/2020 | Echue | |
| Gilead Medica | US375558BG78 | USD | 4.6% | 2 000 USD | 01/09/2035 | 100 | |
| Gilead Medica | US375558BF95 | USD | 3.65% | 2 000 USD | 01/03/2026 | 100 | |
| Gilead Medica | US375558BL63 | USD | 2.5% | 2 000 USD | 01/09/2023 | Echue | |
| Gilead Medica | US375558BN20 | USD | 0% | 2 000 USD | 20/09/2018 | Echue | |
| Gilead Medica | US375558BB81 | USD | 2.55% | 2 000 USD | 01/09/2020 | Echue | |
| Gilead Medica | US375558AS26 | USD | 5.65% | 2 000 USD | 01/12/2041 | 103.825 | |
| Gilead Medica | US375558BD48 | USD | 4.75% | 2 000 USD | 01/03/2046 | 90.453 | |
| Gilead Medica | US375558BM47 | USD | 2.95% | 2 000 USD | 01/03/2027 | 99 | |
| Gilead Medica | US375558AZ68 | USD | 3.5% | 2 000 USD | 01/02/2025 | Echue | |
| Gilead Medica | US375558BE21 | USD | 1.85% | 2 000 USD | 04/09/2018 | Echue | |
| Gilead Medica | US375558CB72 | USD | 4.8% | 2 000 USD | 15/11/2029 | 102.554 | |
| Gilead Medica | US375558BA09 | USD | 4.5% | 2 000 USD | 31/01/2045 | 88.75 | |
| Gilead Medica | US375558CC55 | USD | 5.1% | 15/06/2035 | 102.311 | ||
| Gilead Medica | US375558CA99 | USD | 5.55% | 15/10/2053 | 100 | ||
| Gilead Medica | US375558CD39 | USD | 5.5% | 15/11/2054 | 99.7047 | ||
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology.
Gilead Sciences est une société biopharmaceutique américaine spécialisée dans la découverte, le développement et la commercialisation de traitements contre des maladies graves, notamment le VIH/SIDA, l'hépatite B et C, et le cancer.
Gilead Sciences è un'azienda biofarmaceutica multinazionale focalizzata sullo sviluppo e la commercializzazione di farmaci antivirali, oncologici e di terapie innovative per malattie gravi.